Aileron Therapeutics Stock Target Price and Analyst Consensus
| ALRN Stock | USD 5.00 0.75 17.65% |
The current analyst and expert consensus on Aileron Therapeutics is Strong Buy, with only one strong buy opinion. The current projected Aileron Therapeutics target price consensus is 40.00 with 1 analyst opinions. The most common way Aileron Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Aileron Therapeutics executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Aileron Therapeutics. We encourage you to use your own analysis of Aileron Therapeutics to validate this buy or sell advice. Aileron Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Aileron Therapeutics target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Aileron Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Aileron Stock, please use our How to Invest in Aileron Therapeutics guide.
Lowest Forecast 36.4 | Highest Forecast 44.4 | Target Price 40 |
Aileron |
It's important to approach Aileron Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Aileron Therapeutics price targets
Aileron Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Aileron Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Aileron Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Aileron Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Aileron Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Aileron Therapeutics is a key component of Aileron Therapeutics valuation and have some predictive power on the future returns of a Aileron Therapeutics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aileron Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested over 70 shares | |
 | Manufacturing Invested over 40 shares | |
 | Momentum Invested over 200 shares | |
 | Banking Invested over 30 shares | |
 | Blockchain Invested few shares | |
Check out Macroaxis Advice on Aileron Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Aileron Stock, please use our How to Invest in Aileron Therapeutics guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Aileron Stock analysis
When running Aileron Therapeutics' price analysis, check to measure Aileron Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aileron Therapeutics is operating at the current time. Most of Aileron Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aileron Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aileron Therapeutics' price. Additionally, you may evaluate how the addition of Aileron Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
The data published in Aileron Therapeutics' official financial statements usually reflect Aileron Therapeutics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Aileron Therapeutics. For example, before you start analyzing numbers published by Aileron accountants, it's critical to develop an understanding of what Aileron Therapeutics' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Aileron Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aileron Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Aileron Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Aileron Therapeutics. Please utilize our Beneish M Score to check the likelihood of Aileron Therapeutics' management manipulating its earnings.